Furthermore, these findings were validated in nine human glioma tissues at the protein level through immunohistochemistry staining, as compared to lower grade gliomas (grade 2 and 3), PCK2 is significantly highly expressed in GBM patients (Fig. 1K-L, Fig. S1). The gene discussed is PCK2; the disease is glioma.